Invesco
FULC icon

Invesco’s Fulcrum Therapeutics FULC Stock Holding History

Invesco’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
113,319
+2,194
+2% +$13.3K ﹤0.01% 3315
2026
Q1 		$852K Sell
111,125
-306,064
-73% -$2.84M ﹤0.01% 2938
2025
Q4 		$4.72M Buy
417,189
+293,317
+237% +$2.98M ﹤0.01% 2265
2025
Q3 		$1.14M Sell
123,872
-346,461
-74% -$2.51M ﹤0.01% 2874
2025
Q2 		$3.24M Buy
470,333
+384,566
+448% +$2.06M ﹤0.01% 2388
2025
Q1 		$247K Buy
85,767
+55,791
+186% +$205K ﹤0.01% 3426
2024
Q4 		$141K Sell
29,976
-686
-2% -$2.53K ﹤0.01% 3580
2024
Q3 		$109K Sell
30,662
-381
-1% -$2.83K ﹤0.01% 3605
2024
Q2 		$192K Sell
31,043
-465,636
-94% -$3.53M ﹤0.01% 3631
2024
Q1 		$4.69M Buy
496,679
+20,473
+4% +$183K ﹤0.01% 2278
2023
Q4 		$3.21M Buy
+476,206
New +$2.11M ﹤0.01% 2441
2023
Q2 		– Sell
-12,469
Closed -$35.5K – 3884
2023
Q1 		$35.5K Sell
12,469
-509
-4% -$4.56K ﹤0.01% 3776
2022
Q4 		$94.5K Buy
12,978
+1,737
+15% +$11.3K ﹤0.01% 3837
2022
Q3 		$90K Buy
11,241
+141
+1% +$1.01K ﹤0.01% 3852
2022
Q2 		$55K Sell
11,100
-212,360
-95% -$2.08M ﹤0.01% 3959
2022
Q1 		$5.28M Buy
223,460
+115,993
+108% +$1.64M ﹤0.01% 2348
2021
Q4 		$1.9M Sell
107,467
-488,590
-82% -$9.68M ﹤0.01% 2812
2021
Q3 		$16.8M Buy
+596,057
New +$11.3M ﹤0.01% 1674

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's FULC Position: Q2 2026 in Review

Invesco increased its Fulcrum Therapeutics (FULC) stake by 2% in Q2 2026, buying an estimated $13.3K and bringing the position to 113,319 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

Invesco first reported a position in FULC in Q3 2021 and has held it in 18 quarters since. The position peaked at $16.8M in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Invesco held 113,319 shares of Fulcrum Therapeutics worth $415K as of Q2 2026.
  • Invesco bought 2,194 Fulcrum Therapeutics shares in Q2 2026, an estimated $13.3K.
  • Fulcrum Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3315 holding.
  • Invesco first reported a position in Fulcrum Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • Invesco's Fulcrum Therapeutics position peaked at $16.8M in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.